宫颈脱落细胞高危人乳头瘤病毒DNA分型定量的临床应用

Clinical application of high risk-human papillom virus-DNA typing and quantification in exfoliated cervical cells

  • 摘要: 目的 探讨宫颈脱落细胞高危人乳头瘤病毒DNA(HR-HPV-DNA)分型定量在宫颈癌防治中的意义。方法 采用实时定量PCR-双色荧光探针法,对1 417例体检妇女进行宫颈脱落细胞作HR-HPV-DNA分型定量检测和TCT检测。结果 HR-HPV16是HR-HPV单型别中阳性率最高的型别(19.14%)。HR-HPV-DNA总体阳性率为13.76%,HR-HPV-DNA阳性率和水平随着细胞学诊断的严重程度增加而升高。在宫颈上皮内瘤变(CIN)组,HR-HPV-DNA水平高于正常组、萎缩性鳞状上皮细胞组、轻度炎症组和中度炎症组(P<0.05)。非典型鳞状上皮细胞组HR-HPV-DNA水平高于轻度炎症组(P<0.05)。结论 细胞学诊断的严重程度不仅与HR-HPV的型别有关,还与HR-HPV-DNA的水平有关。

     

    Abstract: Objective To study the significance of high risk-human papillom virus-DNA(HR-HPV-DNA) typing and quantification in prevention and treatment of cervical cancer. Methods HR-HPV-DNA was typed and quantified was detected in exfoliated cervical cells from 1 417 normal females by real-time dual fluorescent probes PCR and 1 417 cases were detected using TCT. Results The positive rate of HR-HPV16 was the highest in all types of HR-HPV,accounting for 19.14%.The total positive rate of HR-HPV-DNA was 13.76%,which increased with the increasing severity of cervical cancer.The HR-HPV-DNA level was significantly higher in cervical intraepithelial neoplasia(CIN) group and atypical squamous cell group than in normal group,atrophic squamous cell group,mild and moderate inflammation groups(P<0.05). Conclusion The severity of cervical cancer is related not only with the HR-HPV type but also with the HR-HPV-DNA level.

     

/

返回文章
返回